Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 498-502

  Lambrecht, Maarten ^a   Dirix, Piet ^a   Van den Bogaert, Walter ^a   Nuyts, Sandra ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Head and neck cancer; Neck management; Radiotherapy; Regional control

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OTORHINOLARYNGOLOGIC NEOPLASMS; SURVIVAL RATE;

EID: 70449890993     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.038     Document Type: Article

References (33)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Döbrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24 (2005) 9-17
3. Mathers S.K., Boschi-Pinto C.D., et al. Global, regional estimates of cancer mortality, incidence by site:II. Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
4. Kamangar F., Dores G.M., and Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24 (2006) 2137-2150
5. Lamont E.B., and Vokes E.E. Chemotherapy in the management of squamous-cell carcinoma of the head and neck. Lancet Oncol 2 (2001) 261-269
6. Vermorken J.B. Medical treatment in head and neck cancer. Ann Oncol 16 (2005) 258-264
7. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
8. Boyd T.S., Harari P.M., Tannehill S.P., et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 20 (1998) 132-137
9. Mabanta S.R., Mendenhall W.M., Stringer S.P., and Cassisi N.J. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 21 (1999) 591-594
10. Barkley Jr. H.T., Fletcher G.H., Jesse R.H., and Lindbergh R.D. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 124 (1972) 462-467
11. Mendenhall W.M., Million R.R., and Cassisi N.J. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12 (1986) 733-740
12. Pignon J.P., Bourhis J., Domenge C., and Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
13. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-853
14. Ang K.K., and Garden A.S. Radiotherapy for head and neck cancer: Indications and techniques. 2nd ed. (2002), Lippincott Williams &Wilkins Publishers, Philadelphia
15. Mendenhall W.M., Villaret D., Amdur R.J., Hinerman R.W., and Mancuso A. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 24 (2002) 1012-1018
16. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Onc 26 (2008) 3582-3589
17. International Union Against Cancer (UICC): TNM classification of malignant tumours. In: Sobin LH, Wittekind Ch, editors, 6th ed. New York: Wiley; 2002.
18. Nuyts S., Dirix P., Hermans R., et al. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer. Head Neck 29 (2007) 720-730
19. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
20. Nuyts S., Dirix P., Clement P.M., et al. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 73 (2009) 1088-1095
21. Grégoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
22. Weisman R.A., and Robbins K.T. Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin North Am 31 (1998) 773-784
23. Sanguineti G., Corvo R., Benasso M., et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 21 (1999) 223-228
24. Bernier J., and Bataini J.P. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases. Radiother Oncol 6 (1986) 87-103
25. Liauw S.L., Amdur R.J., Morris C.G., Werning J.W., Villaret D.B., and Mendenhall W.M. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Head Neck 29 (2007) 715-719
26. Hermans R., Op de Beeck K., Van den Bogaert W., et al. The relation of CT-determined tumour parameters and local and reginal outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 50 (2001) 37-45
27. Ahmed K.A., Robbins K.T., Wong F., and Salazar J.E. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 110 (2000) 1789-1793
28. Forest V.I., Nguyen-Tan P.F., and Tabet J.C. Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma. Head Neck 28 (2006) 1099-1105
29. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., and Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
30. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
31. Schoenfeld G.O., Amdur R.J., Morris C.G., et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Onc Biol Phys 71 (2008) 377-385
32. Bussels B., Maes A., Hermans R., et al. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72 (2004) 119-127
33. Haraf D.J., Rosen F.R., and Stenson K. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 9 (2003) 5936-5943